Abstract-An enhancement of superoxide (O 2 Ϫ ) activity was shown to contribute to the development of hypertension induced by NO deficiency. To better understand the mechanistic role of O 2 Ϫ in this NO-deficient hypertension, we evaluated the renal responses to acute intraarterial administration of an O 2 Ϫ scavenger, tempol (50 g/min per 100 g of body weight) in anesthetized male Sprague-Dawley rats treated with NO synthase inhibitor nitro-L-arginine methyl ester (15 mg/kg per day in drinking water, nϭ7) for 4 weeks, which caused increases in mean arterial pressure (146Ϯ3 versus 124Ϯ2 mm Hg) compared with normotensive control rats (nϭ6). Hypertensive rats had higher renal vascular resistance (29Ϯ2 versus 20Ϯ1 mm Hg/mL per minute per gram), as well as lower renal blood flow (5.2Ϯ0.3 versus 6.3Ϯ0.2 mL/min per gram; cortical blood flow, 153Ϯ13 versus 191Ϯ8 perfusion units; medullary blood flow, 43Ϯ2 versus 51Ϯ3 perfusion units) and glomerular filtration rate (0.69Ϯ0.04 versus 0.90Ϯ0.05 mL/min per gram) without a significant difference in urinary sodium excretion (0.81Ϯ0.07 versus 0.86Ϯ0.12 mol/min per gram) compared with normotensive rats. Urinary 8-isoprostane excretion rate (6.8Ϯ0.7 versus 4.5Ϯ0.3 pg/min per gram) was higher in hypertensive than normotensive rats. Intraarterial infusion of tempol did not alter renal function in normotensive rats. However, tempol significantly decreased renal vascular resistance by 12Ϯ2% and urinary 8-isoprostane excretion rate by 24Ϯ4% and increased renal blood flow by 10Ϯ2%, cortical blood flow by 9Ϯ2%, medullary blood flow by 15Ϯ6%, glomerular filtration rate by 11Ϯ3%, and urinary sodium excretion by 19Ϯ5% in hypertensive rats. These data indicate that enhanced O 2 Ϫ activity modulates renal hemodynamics and excretory function during reduced NO production and, thus, contributes to the pathophysiology of the NO-deficient form of hypertension. A n imbalance between the production and the degradation of reactive oxygen species such as superoxide anion (O 2 Ϫ ) leads to the condition termed as "oxidative stress." It has been suggested that oxidative stress is involved in the pathophysiology of many forms of hypertension. 1-3 Treatment with an O 2 Ϫ scavenging agent, tempol (4-hydroxytetramethylpiperidime-1-oxyl), significantly reduces blood pressure in different hypertensive models 4,5 indicating that O 2 Ϫ plays a role in the development of hypertension. Recently, we also demonstrated that chronic treatment with tempol attenuated the development of hypertension and salt sensitivity in rats induced by chronic inhibition of NO synthase (NOS) in rats. 6 These results indicate that an enhanced O 2 Ϫ generation is involved in the pathogenesis of an NO-deficient form of hypertension. However, the exact mechanistic role of O 2 Ϫ in mediating the salt sensitivity and hypertension in the condition of NO deficiency has not yet been clearly defined.NO acts as an endogenous antioxidative agent by reacting with O 2 Ϫ generated in the living tissues, thus it provides a protective function aga...